Semen Characteristics and Serum and Seminal Plasma Hormones in Drug-Induced Hyperprolactinaemia

5Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Semen volume, density, motility, viability, and morphology of spermatozoa, and serum and seminal plasma levels of the hormones FSH, LH, prolactin, progesterone, 17-a-hydroxyprogesterone, androstenedione, testosterone, dihidrotestosterone, and estradiol 17-p have been measured in 22 men subjected to experimental hyperprolactinaemia by the simultaneous administration of the antidopaminergic drugs metoclopramide and sulpiride. Hyperprolactinaemia produces a decrease of semen volume and seminal quality. In hyperprolactinaemia, normozoospermic patients had an increase of serum androstenedione. In both norrno- and oligozoospermic groups, a decrease of serum testosterone was observed. Hyperprolactinaemia also causes an inhibition of the secretory activity of the accessory sexual glands of the reproductive tract, as well as either a decrease of 17-ketosteroid reductase or an increase of 17-a-hydroxysteroid dehydrogenase (enzymes that participate in the androstenedione-testosterone interconversions). This change appears to be more pronounced in individuals with good seminal quality. © 1982, Informa UK Ltd. All rights reserved.

Cite

CITATION STYLE

APA

García Díez, L. C., & Gonzalez Buitrago, J. M. (1982). Semen Characteristics and Serum and Seminal Plasma Hormones in Drug-Induced Hyperprolactinaemia. Archives of Andrology, 9(4), 311–317. https://doi.org/10.3109/01485018208990257

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free